Rosiglitazone plus metformin is effective and well tolerated in clinical practice: results from large observational studies in people with type 2 diabetes
Rosak, C., Petzoldt, R., Wolf, R., Reblin, T., Dehmel, B., Seidel, D.
Published in International journal of clinical practice (Esher) (01.10.2005)
Published in International journal of clinical practice (Esher) (01.10.2005)
Get full text
Journal Article
Rosiglitazone is effective and well-tolerated in a range of therapeutic regimens during daily practice in patients with type 2 diabetes
ROSAK, C., STANDL, E., REBLIN, T., STAMMER, H., SEIDEL, D. K.
Published in International journal of clinical practice (Esher) (01.09.2006)
Published in International journal of clinical practice (Esher) (01.09.2006)
Get full text
Journal Article
Cellular uptake of lipoprotein[a] by mouse embryonic fibroblasts via the LDL receptor and the LDL receptor-related protein
Reblin, T, Niemeier, A, Meyer, N, Willnow, T E, Kronenberg, F, Dieplinger, H, Greten, H, Beisiegel, U
Published in Journal of lipid research (01.10.1997)
Published in Journal of lipid research (01.10.1997)
Get full text
Journal Article
Lipoprotein(a) in the arterial wall
Beisiegel, U, Niendorf, A, Wolf, K, Reblin, T, Rath, M
Published in European heart journal (01.08.1990)
Published in European heart journal (01.08.1990)
Get more information
Journal Article
Detection and quantification of lipoprotein(a) in the arterial wall of 107 coronary bypass patients
Rath, M, Niendorf, A, Reblin, T, Dietel, M, Krebber, H J, Beisiegel, U
Published in Arteriosclerosis (Dallas, Tex.) (01.09.1989)
Published in Arteriosclerosis (Dallas, Tex.) (01.09.1989)
Get more information
Journal Article
ORIGINAL PAPER: Rosiglitazone is effective and well-tolerated in a range of therapeutic regimens during daily practice in patients with type 2 diabetes
ROSAK, C, STANDL, E, Reblin, T, Stammer, H, Seidel, D K
Published in International journal of clinical practice (Esher) (01.09.2006)
Published in International journal of clinical practice (Esher) (01.09.2006)
Get full text
Journal Article
Rosiglitazone is effective and well-tolerated in a range of therapeutic regimens during daily practice in patients with type 2 diabetes: ROSIGLITAZONE IS EFFECTIVE IN DAILY PRACTICE
ROSAK, C., STANDL, E., REBLIN, T., STAMMER, H., SEIDEL, D. K.
Published in International journal of clinical practice (Esher) (01.09.2006)
Published in International journal of clinical practice (Esher) (01.09.2006)
Get full text
Journal Article
Determination of splenic blood flow by inhalation of radioactive rare gases
Huchzermeyer, H, Schmitz-Feuerhake, I, Reblin, T
Published in European journal of clinical investigation (01.10.1977)
Published in European journal of clinical investigation (01.10.1977)
Get more information
Journal Article
ORIGINAL PAPER: Rosiglitazone plus metformin is effective and well tolerated in clinical practice: results from large observational studies in people with type 2 diabetes
Rosak, C, Petzoldt, R, Wolf, R, Reblin, T, Dehmel, B, Seidel, D
Published in International journal of clinical practice (Esher) (01.10.2005)
Published in International journal of clinical practice (Esher) (01.10.2005)
Get full text
Journal Article
Rosiglitazone plus metformin is effective and well tolerated in clinical practice: results from large observational studies in people with type 2 diabetes: Rosiglitazone Plus Metformin for Type 2 Diabetes
Rosak, C., Petzoldt, R., Wolf, R., Reblin, T., Dehmel, B., Seidel, D.
Published in International journal of clinical practice (Esher) (01.10.2005)
Published in International journal of clinical practice (Esher) (01.10.2005)
Get full text
Journal Article
Renal handling of human apolipoprotein(a) and its fragments in the rat
Reblin, T, Donarski, N, Fineder, L, Bräsen, J H, Dieplinger, H, Thaiss, F, Stahl, R A, Beisiegel, U, Wolf, G
Published in American journal of kidney diseases (01.09.2001)
Published in American journal of kidney diseases (01.09.2001)
Get more information
Journal Article
Avandamet® (Rosiglitazon+Metformin) verbessert bei mit Metformin vorbehandelten Patienten effizient HbA1c, NBZ, Blutdruck und hsCRP
Liebl, A, Löbner, K, Dietlein, M, Banik, N, Reblin, T, Seidel, D
Published in Diabetologie und Stoffwechsel (19.06.2006)
Published in Diabetologie und Stoffwechsel (19.06.2006)
Get full text
Conference Proceeding
Gender-specific differences in association of Lp(a) with the severity of coronary atherosclerosis
Stiel, S.M., Nienaber, C.A., Reblin, T., Bu¨hrlen, M., Meinertz, T.
Published in Atherosclerosis (01.09.1994)
Published in Atherosclerosis (01.09.1994)
Get full text
Journal Article
Preventing infarct in the diabetic patient. Lowering blood glucose and HbA1c are not enough
Reblin, T, Seidel, D, Stein, D, Görtz, A, Lander, T
Published in MMW Fortschritte der Medizin (08.05.2003)
Get more information
Published in MMW Fortschritte der Medizin (08.05.2003)
Journal Article